Incyte (INCY)

Add to Watchlists
Create an Alert
43.96 +0.86  +2.00% NASDAQ Apr 16, 5:00PM BATS Real time Currency in USD
View Full Chart
INCY Price Chart
View All Events

INCY Events

Date Type Description
Feb 12 Misc Q4 2013 Incyte Corporation Earnings Conference Call
Feb 12 Earnings Q4 2013 Incyte Corporation Earnings. Estimate: -0.09.
Oct 31 Misc Q3 2013 Incyte Corporation Earnings Conference Call
Oct 31 Earnings Incyte to Report Third Quarter 2013 Financial Results on October 31. Estimate: -0.13.
Aug 01 Misc Q2 2013 Incyte Corporation Earnings Conference Call
Aug 01 Earnings Incyte to Report Second Quarter 2013 Financial Results on August 1. Estimate: 0.10.
May 30 Misc AGM Event for Incyte Corp.
May 02 Misc Q1 2013 Incyte Corporation Earnings Conference Call
May 02 Earnings Incyte to Report First Quarter 2013 Financial Results on May 2. Estimate: -0.13.
View All Performance Charts

INCY Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Incyte is up 109.0% over the last year vs S&P 500 Total Return up 22.52%, Amgen up 8.42%, and Novartis up 18.58%.

Get Quote for

PDF Report for INCY

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download INCY Pro Report PDF
Advertisement

Portfolio Strategies Featuring INCY

Did Incyte make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

INCY Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Delaware
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Research and Development in Biotechnology
  • NAICS Code: 541711
  • NAICS Industry: Scientific Research and Development Services
  • NAICS Industry Code: 5417
  • NAICS Sector: Professional, Scientific, and Technical Services
  • NAICS Sector Code: 54

Incyte Corp. is a drug discovery and development company, focused on developing small molecule drugs to treat serious unmet medical needs. The company's product pipeline is focused in the areas of oncology and inflammation and includes compounds in various stages of development, ranging from preclinical to late-stage development. It has a collaborative research and license agreements with Novartis International Pharmaceutical Ltd.; Eli Lilly and Company; and Pfizer Inc. The company was founded by Roy A. Whitfield, Jeffrey C. Collison, Randal W. Scott and Arthur Dony Strosberg in 1991 and is headquartered in Wilmington, Delaware.

Recent Quotes

Symbol Price Chg Chg % Market Cap
INCY 43.96 +0.86 +2.00% 7.165B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.